ESC presentations from August now online
BearDownAZ
------------------------------------------------------------------------------------------
A novel approach for high CV risk patients with diabetes: The potential of epigenetics
August 28th 2016, ESC, Rome
Kausik Ray, MD - Imperial College London, United Kingdom:
"The high risk diabetes patient with cardiovascular disease: What else can we target to reduce cardiovascular risk?"
Jorge Plutzky, MD - Brigham and Women’s Hospital, Harvard Medical School, Boston, USA:
"Understanding BET inhibition as a novel pathway for cardiovascular risk modulation"
John Kastelein, MD - Academic Medical Centre, Amsterdam, The Netherlands:
"BET inhibition in cardiovascular disease: A new dawn?"
